Paper Details

  1. Home
  2. Paper Details

Broad Antiviral Effects of <i>Echinacea purpurea</i> against SARS-CoV-2 Variants of Concern and Potential Mechanism of Action.

Author: D'AlessandroSarah, DelbueSerena, DolciMaria, ParianiElena, PleschkaStephan, SadasivamKannan, ShehataMahmoud, VimalanathanSelvarani

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

<i>Echinacea purpurea</i> extract (EF) broadly inhibited the propagation of seven SARS-CoV-2 variants of concern (VOCs) and the entry of SARS-CoV-2 pseudoparticles. This suggests that EF may offer a supportive addition to vaccination endeavors in the control of existing and future SARS-CoV-2 virus mutations.
Paper Details　
Original Abstract of the Article :
SARS-CoV-2 variants of concern (VOCs) represent an alarming threat as they show altered biological behavior and may escape vaccination effectiveness. Broad-spectrum antivirals could play an important role to control infections. The activity of <i>Echinacea purpurea</i> (Echinaforce<sup>&#174;</sup> ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694187/

データ提供：米国国立医学図書館（NLM）

Echinacea: A Potential Oasis Against SARS-CoV-2 Variants?

The landscape of [SARS-CoV-2] infection is constantly evolving, with new variants emerging as a continuous challenge. This research explores the potential of [Echinacea purpurea (Echinaforce® extract, EF)] as a [broad-spectrum antiviral] agent against various SARS-CoV-2 variants of concern (VOCs). The researchers investigated EF's antiviral activity against [seven VOCs], including [alpha, beta, gamma, delta, Scottish, eta, and omicron], utilizing [in vitro and in silico approaches].

Seeking Shelter in the Oasis of Echinacea

The study's findings suggest that EF extract demonstrated [broad antiviral activity] against all seven SARS-CoV-2 VOCs tested. This suggests that EF might offer a [potential therapeutic] option for managing SARS-CoV-2 infections, including those caused by emerging variants.

Navigating the Sands of Viral Infections

As a desert wanderer, I encourage caution in interpreting these findings. While EF shows promise, it's essential to remember that it's not a substitute for [vaccination] or other proven therapies. However, this research offers a potential path toward [supportive therapies] that could complement existing treatments for SARS-CoV-2 infections.

Dr. Camel's Conclusion

Echinacea purpurea extract demonstrates potential as a broad-spectrum antiviral against SARS-CoV-2 variants of concern. Further research is needed to confirm its efficacy and safety in clinical settings, but it offers a glimmer of hope in the ongoing fight against COVID-19.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-09-18
Further Info :

Pubmed ID

36363737

DOI: Digital Object Identifier

PMC9694187

Related Literature

Article Analysis
・Effective treatment of echinacea
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.